Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer: Epigenetic control of the RUNX2 P1 promoter

1 May 2019

Abstract excerpt

Lung cancer has a high mortality rate in men and women worldwide. Approximately 15% of diagnosed patients with this type of cancer do not exceed the 5-year survival rate. Unfortunately, diagnosis is established in advanced stages, where other tissues or organs can be affected. In recent years, lineage-specific transcription factors have been associated with a variety of cancers. One such transcription factor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Lung Cancer Treatments and Mutations
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31109257
DOI: 10.1177/1010428319851014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer: Epigenetic control of the RUNX2 P1 promoterPMID 31109257Read ↗

Clinical significance of RUNX2 expression in patients with nonsmall cell lung cancer: a 5-year follow-up studySemantic proximity Read ↗

RUNX3 downregulation in human lung adenocarcinoma is independent of p53, EGFR or KRAS status.Semantic proximity Read ↗

Epigenetic analysis on RUNX3 mislocalization and its association with tumor microenvironment alteration in non-small cell lung cancerSemantic proximity Read ↗

PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathwaySemantic proximity Read ↗

RUNX family: Oncogenes or tumor suppressors (Review)Semantic proximity Read ↗

RUNX family: Regulation and diversification of roles through interacting proteins.Semantic proximity Read ↗

TEAD transcription factor family emerges as a promising therapeutic target for oral squamous cell carcinomaSemantic proximity Read ↗

Hematopoietic Transcription Factor RUNX1 is Essential for Promoting Macrophage–Myofibroblast Transition in Non‐Small‐Cell Lung CarcinomaSemantic proximity Read ↗

Nuclear TARBP2 drives oncogenic dysregulation of RNA splicing and decaySemantic proximity Read ↗

Pan-cancer landscape of the RUNX protein family reveals their potential as carcinogenic biomarkers and the mechanisms underlying their actionSemantic proximity Read ↗

Runx2 in normal tissues and cancer cells: A developing storySemantic proximity Read ↗

ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.